A cohort examination to establish reporting of the remit and function of Trial Steering Committees in randomised controlled trials

被引:2
|
作者
Conroy, Elizabeth J. [1 ,2 ]
Arch, Barbara [2 ]
Harman, Nicola L. [1 ,2 ]
Lane, J. Athene [3 ]
Lewis, Steff C. [4 ]
Norrie, John [4 ]
Sydes, Matthew R. [5 ,6 ]
Gamble, Carrol [1 ,2 ]
机构
[1] Univ Liverpool, Dept Biostat, MRC North West Hub Trials Methodol Res, Block F Waterhouse Bldg,1-5 Brownlow St, Liverpool L69 3GL, Merseyside, England
[2] Univ Liverpool, Clin Trials Res Ctr, Liverpool, Merseyside, England
[3] Univ Bristol, Bristol Randomised Trials Collaborat, Bristol, Avon, England
[4] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland
[5] UCL, Inst Clin Trials & Methodol, MRC Clin Trials Unit, London, England
[6] London MRC Hub Trials Methodol Res, London, England
基金
英国医学研究理事会;
关键词
Trials; Oversight committee; Trial Steering Committee; Executive Committee; Clinical Trial; Data Monitoring Committee; Randomised controlled trial;
D O I
10.1186/s13063-017-2300-1
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: The DAMOCLES project established a widely used Data Monitoring Committee (DMC) Charter for randomised controlled trials (RCTs). Typically, within the UK, the DMC is advisory and recommends to another executive body; the Trial Steering Committee (TSC). Despite the executive role of the TSC, the CONSORT Statement does not explicitly require reporting of TSC activity, although is included as an example of good reporting. A lack of guidance on TSC reporting can impact transparency of trial oversight, ultimately leading to a misunderstanding regarding role and, subsequently, further variation in practice. This review aimed to establish reporting practice of TSC involvement in RCTs, and thus make recommendations for reporting. Methods: A cohort examination identifying reporting practice was undertaken. The cohort comprised RCTs published in three leading medical journals (the British Medical Journal, The Lancet and the New England Journal of Medicine) within 6 months in 2012 and the full NIHR HTA Monograph series. Details of TSC constitution and impact were extracted from main publications and published supplements. Results: Of 415 publications, 264 were eligible. These were typical in terms of trial design. Variations in reporting between journals and monographs was notable. TSC presence was identified in approximately half of trials (n = 144), of which 109 worked alongside a DMC. No publications justified not convening a TSC. When reported, the role of the committee and examples of impact in design, conduct and analysis were summarised. Conclusions: We present the first review of reporting TSC activity in the published academic literature. An absence of reporting standards with regards to TSC constitution, activity and impact on trial conduct was identified which can influence transparency of reporting trial oversight. Consistent reporting is vital for the benefits and impact of the TSC role to be understood to support adoption of this oversight structure and reduce global variations in practice.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Design and reporting of randomised controlled trials on treatments for cutaneous leishmaniasis
    Gonzalez, U.
    Pinart, M.
    Reveiz, L.
    Alvar, J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2008, 128 (10) : 2560 - 2560
  • [42] Reporting of sample size calculation in randomised controlled trials: review
    Charles, Pierre
    Giraudeau, Bruno
    Dechartres, Agnes
    Baron, Gabriel
    Ravaud, Philippe
    BMJ-BRITISH MEDICAL JOURNAL, 2009, 338 : 1256
  • [43] Prospective reporting of statistical analysis plans for randomised controlled trials
    Karla Hemming
    Anna Kearney
    Carrol Gamble
    Tianjing Li
    Peter Jüni
    An-Wen Chan
    Matthew R. Sydes
    Trials, 21
  • [44] Counting, analysing and reporting exacerbations of COPD in randomised controlled trials
    Aaron, S. D.
    Fergusson, D.
    Marks, G. B.
    Suissa, S.
    Vandemheen, K. L.
    Doucette, S.
    Maltais, F.
    Bourbeau, J. F.
    Goldstein, R. S.
    Balter, M.
    O'Donnell, D.
    FitzGerald, M.
    THORAX, 2008, 63 (02) : 122 - 128
  • [45] A systematic review of outcome reporting in achalasia randomised controlled trials
    Gray, R. T.
    Kennedy, R.
    Kennedy, J. A.
    BRITISH JOURNAL OF SURGERY, 2016, 103 : 119 - 119
  • [46] Prospective reporting of statistical analysis plans for randomised controlled trials
    Hemming, Karla
    Kearney, Anna
    Gamble, Carrol
    Li, Tianjing
    Juni, Peter
    Chan, An-Wen
    Sydes, Matthew R.
    TRIALS, 2020, 21 (01)
  • [47] REPORTING QUALITY OF RANDOMISED CONTROLLED TRIALS IN SOLID ORGAN TRANSPLANTATION
    Liu, Liang Q.
    Pengel, Liset H. M.
    Morris, Peter J.
    TRANSPLANT INTERNATIONAL, 2011, 24 : 74 - 74
  • [48] Reporting on quality of life in randomised controlled trials: bibliographic study
    Sanders, C
    Egger, M
    Donovan, J
    Tallon, D
    Frankel, S
    BRITISH MEDICAL JOURNAL, 1998, 317 (7167): : 1191 - 1194
  • [49] Analysis and reporting of adverse events in randomised controlled trials: a review
    Phillips, Rachel
    Hazell, Lorna
    Sauzet, Odile
    Cornelius, Victoria
    BMJ OPEN, 2019, 9 (02):
  • [50] Reporting on Quality of Life in Randomised Controlled Trials in Gastrointestinal Surgery
    Bridoux, Valerie
    Moutel, Gregoire
    Lefebure, Benoit
    Scotte, Michel
    Michot, Francis
    Herve, Christian
    Tuech, Jean-Jacques
    JOURNAL OF GASTROINTESTINAL SURGERY, 2010, 14 (01) : 156 - 165